1. Home
  2. SFHG vs LEXX Comparison

SFHG vs LEXX Comparison

Compare SFHG & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SFHG

Samfine Creation Holdings Group Limited Ordinary Share

HOLD

Current Price

$2.48

Market Cap

16.2M

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.75

Market Cap

16.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFHG
LEXX
Founded
1993
2004
Country
Hong Kong
Canada
Employees
N/A
7
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.2M
16.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SFHG
LEXX
Price
$2.48
$0.75
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
19.3K
138.7K
Earning Date
10-30-2025
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$601.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.32
$0.46
52 Week High
$3.17
$1.75

Technical Indicators

Market Signals
Indicator
SFHG
LEXX
Relative Strength Index (RSI) 67.53 57.88
Support Level $0.64 $0.62
Resistance Level $3.17 $0.87
Average True Range (ATR) 0.15 0.08
MACD -0.07 0.01
Stochastic Oscillator 78.45 70.01

Price Performance

Historical Comparison
SFHG
LEXX

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: